In 2010, the Gavi Board approved a second five-year strategy to support its mission and a business plan to guide implementation
Gavi's second five year strategy (2011-2015), approved by the Gavi Board in June 2010, draws on lessons from the previous 10 years and sets the roadmap for the next stage of the Vaccine Alliance's mission: completing the introduction of pentavalent vaccines and accelerating the delivery of a new generation of life-saving vaccines, in particular rotavirus and pneumococcal, to developing countries.
It also lays the groundwork for the achievement of Gavi's objectives beyond 2015.
The 2011-15 strategy has four goals, each supporting Gavi's overall mission:
The 2011-2015 strategy also includes three cross-cutting areas: Monitoring and Evaluation, Advocacy, Communication and Public Policy, and Policy.
Monitoring and evaluation
Monitoring and evaluation (M&E) is essential for improving performance and ensuring the Vaccine Alliance is using its resources effectively.
M&E is a cross-cutting function and activities are conducted by the Secretariat, Vaccine Alliance partners and countries themselves. Gavi has developed a Monitoring and Evaluation Framework and Strategy, which is intended to guide Gavi's work in M&E for the period 2011-2015.
As part of the Health Systems Funding Platform, a working group has developed a framework for the monitoring and evaluation of health system strengthening investments and a joint work plan for operationalising this framework in countries receiving support.
Advocacy, communications and public policy
Scaled-up communications and advocacy efforts are critical for engaging stakeholders. Gavi's advocacy, communications and public policy has three priorities:
- raise understanding of the value of health, immunisation and Gavi through enhanced communications and targeted media relations;
- mobilise and empower new networks of advocates to inform Gavi's policies, support fundraising and help achieve its strategic goals;
- engage in development aid policy settings to ensure endorsement of Gavi, immunisation and health.
Gavi is regularly adapting its policies to ensure that countries are supported in the most effective and efficient way to reach the 2015 targets defined through the strategy.
In November 2010, the Gavi Board approved a five-year 2011-2015 business plan designed to implement the strategy and ensure that Gavi's day-to-day activities deliver on its overall mission. The 2011-15 business plan includes: